Alternatively, hold down the Ctrl strong> '/' CMD 'key and press + to enlarge or' - 'on the keyboard to reduce the text size.

100%

High contrast mode is an accessibility feature for people with visual impairment.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

Protection against falsified medicine

The objective of EU Directive 2011/62 is to protect prescription-only medicinal products from being falsified. Packaging for such medicinal products will bear new safety features and a unique identifier. Throughout EU a common repositories system will verify prescriptive drugs before it is delivered to a patient.

The deadline is February 2019

From February 9th 2019, it will no longer be possible for falsifiers to introduce falsified, and sometimes life-threatening products, into the legal supply chain. Read more about the medicines supply chain and general information about the new regulations here:

The new regulations will be effective in:

Timeline

EU Directive published (2011)

Del. Regulation published (2016)

EU Directive implemented (2019)

News and project updates

See more news and project updates

Nomvec in the news

Kai Mjaanes, the General Manager of Nomvec, was interviewed by Norsk Farmaceutisk Tidsskrift. February 9th, 2019 is approaching fast, and much work remains. But Kai is confident that the verification system will be in place in time.

Continue reading
See more project updates